NEXGEL, Inc. manufactures aqueous, electron beam crosslinked, high water content hydrogels and polymeric gels. The company is headquartered in Langhorne, Pennsylvania.
| Revenue (TTM) | $12.07M |
| Gross Profit (TTM) | $4.23M |
| EBITDA | $-4.25M |
| Operating Margin | -68.00% |
| Return on Equity | -115.10% |
| Return on Assets | -18.70% |
| Revenue/Share (TTM) | $1.46 |
| Book Value | $0.51 |
| Price-to-Book | 0.51 |
| Price-to-Sales (TTM) | 0.14 |
| EV/Revenue | 0.787 |
| EV/EBITDA | -0.85 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 27.80% |
| Shares Outstanding | $9.75M |
| Float | $7.70M |
| % Insiders | 14.02% |
| % Institutions | 13.67% |
Volatility is currently expanding
NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation Transcript
LANGHORNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced dial-in details for its previously announced investor update call to be held on September 24, 2026, at 4:15 p.m. Eastern Time.
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians to provide solutions that drive better outcomes, streamline care, and elevate the patient experience, today announced the date for the investor update call referenced in its August 17, 2026 earnings release, at which time the Company indicated it expected to host the call on or around September 15, 2026. The Company will now host the call on September 24, 2026, at 4:15 p.m. Eastern Time.
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day LANGHORNE, Pa.
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23rd to Tuesday, April 21st, 2026, at 4:30 P.M. ET.
LANGHORNE, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its shareholder update conference call to April 23, 2026, at 4:30 P.M. ET.
LANGHORNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its shareholder update conference call to April 15, 2026, at 4:30 P.M. ET.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NXGL and any ticker you trade — then tracks every position and per-strategy win rate.
